Cargando…
Targeting the autophagy-lysosomal pathway in Huntington disease: a pharmacological perspective
The autophagy-lysosomal pathway (ALP) is the major biological pathway responsible for clearing intracellular protein aggregates, therefore a promising target for treating diseases featuring the accumulation of aggregation-prone proteins, such as Huntington disease (HD). However, accumulating evidenc...
Autores principales: | Yang, Junsheng, Zhang, Chaoyue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248240/ https://www.ncbi.nlm.nih.gov/pubmed/37304076 http://dx.doi.org/10.3389/fnagi.2023.1175598 |
Ejemplares similares
-
Protein Aggregation and Dysfunction of Autophagy-Lysosomal Pathway: A Vicious Cycle in Lysosomal Storage Diseases
por: Monaco, Antonio, et al.
Publicado: (2020) -
TFEB Dependent Autophagy-Lysosomal Pathway: An Emerging Pharmacological Target in Sepsis
por: Liu, Xin, et al.
Publicado: (2021) -
Interplay Between the Autophagy-Lysosomal Pathway and the Ubiquitin-Proteasome System: A Target for Therapeutic Development in Alzheimer’s Disease
por: Bustamante, Hianara A., et al.
Publicado: (2018) -
Studying Huntington’s Disease in Yeast: From Mechanisms to Pharmacological Approaches
por: Hofer, Sebastian, et al.
Publicado: (2018) -
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease
por: Rivero-Ríos, Pilar, et al.
Publicado: (2016)